Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/1/18 → 3/4/22 |
Financiación
- Novartis (domestic): 385.744,00 US$
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CNP520 in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (AD)
- Jicha, Gregory (PI)
- Bardach, Shoshana (Former CoI)
- Caban-Holt, Allison (Former CoI)